Professional Documents
Culture Documents
Closure of Major Diabetic Foot Wounds and Defects With External Fixation
Closure of Major Diabetic Foot Wounds and Defects With External Fixation
24 (2007) 519–528
* Corresponding author.
E-mail address: alioznur@yahoo.com (A. Oznur).
0891-8422/07/$ - see front matter Crown Copyright Ó 2007 Published by Elsevier Inc. All rights reserved.
doi:10.1016/j.cpm.2007.03.013 podiatric.theclinics.com
520 OZNUR & ZGONIS
albumin levels greater than 3.5 g/dL are a few of the tests assessing the
patient’s overall medical status and compliance.
Most diabetic foot infections are caused by a mixture of aerobic and an-
aerobic pathogens; however, the most common organisms cultured are the
aerobic gram-positive cocci, including Staphylococcus aureus, coagulase-
negative staphylococci, and group B streptococci. Some of the aerobic
gram-negative organisms frequently cultured are Proteus species, Eschericia
coli, and other Enterobacteriaceae. Enterococcus and Corynebacterium spe-
cies can also be considered as potential pathogens in foot infection. Pseudo-
monas aeruginosa is found in no more than 10% to 20% of diabetic foot
cultures [4,5].
The treatment of diabetic patients who have large ulcers and underlying os-
teomyelitis is not well-described in the current literature, however. Currently,
there are only a few reports describing salvage of the diabetic foot with exter-
nal fixation in the English literature. Surgeons worldwide have been using ex-
ternal fixators for all types of fracture management, arthrodeses, complex
deformities, limb lengthening, and osteotomy stabilization. External fixators
are able to perform multiplane corrections, including distraction, compres-
sion, angulation, translation, stabilization, and neutralization [6–12].
In addition, procedures such as repeated debridements, dressing changes,
skin grafting, and bone grafting can be performed without disturbing the
fixation. External fixation can be used to treat defects of practically any
size after aggressive resection. External fixation can provide good stability
in those patients who have severe osteoporosis caused by infection, disuse,
or diabetes mellitus. Application of external fixation is performed rapidly
and often under spinal or local anesthetic. External fixation pins and wires
are not benign in the setting of bone and soft tissue infection. Safe corridors
for pins or wires should be chosen with caution.
Closure of large defects after resection of the necrotic bone with external
fixation is a powerful modality that has the ability to save extremities that
normally would go onto amputation; however, caution should be taken to
avoid creating a useless, permanently painful, or senseless limb. Relative
contraindications for this approach include but are not limited to the follow-
ing conditions: venous stasis disease, complex regional pain syndrome, non-
ambulatory status of the patient, and noncompliance [13–15].
The surgical technique differs in terms of the anatomical location of the
ulcer, soft tissue defect, and osteomyelitis. The goal of this suggested proto-
col and treatment is a shorter hospital stay, limited antibiotic administra-
tion, and the achievement of functionally stable feet when compared with
other conventional methods.
Fig. 1. An initial presentation of an infected calcaneus with a large ulceration (A), followed by
an aggressive debridement and partial calcanectomy (B), an Ilizarov external fixator with hinges
to decrease the soft tissue defect in an equinus position (C), and removal of the external fixator 6
weeks after the operation with an uneventful recovery (D).
the bone cement is removed, an Ilizarov external fixation frame is used with
pin placement outside of the infected area, to hold the hindfoot and midfoot
under compression and alignment. When all of the ulcerations and previous
wounds have healed, the hindfoot is fixed to the forefoot with multiple per-
cutaneous cannulated screws, and the external fixation device is removed.
The patients are mobilized in an ankle foot orthosis with custom footplate,
lined with pressure-dissipating material. Some of the complications associ-
ated with this procedure include but are not limited to the following: persis-
tent infection, soft tissue dehiscence, overcorrection, undercorrection,
pseudoarthrosis, and amputation. Pseudoarthrosis may be an acceptable re-
sult if the foot is stable and ulcer-free (Fig. 2).
Fig. 2. Initial presentation of a large midfoot ulcer and osteomyelitis of multiple bones (A), fol-
lowed by a large midfoot bony and soft tissue resection (B), and external fixation device to allow
narrowing of the associated defect (C). Eventually, the wounds healed with the application of
a split-thickness skin graft (D), and the external fixator was removed 7 weeks after the initial
surgery followed by percutaneous cannulated screw insertion to further stabilize the foot (E).
affects only the width of the forefoot. In cases of an extensive forefoot infec-
tion and gangrene, multiple central ray resections may be required. Single-
ray resection of the one of the three central rays is technically more difficult
than the border ray resections.
The contiguous ulcer site provides a portal of entry for pathogens, which
can result in an infection of both soft tissue and bone. Metatarsophalangeal
joints are in close proximity to one another, and osteomyelitis can easily
524 OZNUR & ZGONIS
the olive wires. Medial and lateral olive wires are inserted and fixed to exter-
nal fixation device. The amount of tensioning of the wires (70–90 kg) de-
pends on the bone quality of the metatarsals, and the soft tissue defect.
The midtarsal half ring is attached to the half ring of the hindfoot with
threaded rods. External fixation devices may or may not extend to the ankle.
The wounds are then closed with interrupted sutures without any tension.
Patients are mobilized in a custom-made boot when the pain and swelling
has subsided. The described technique is used in patients who need more
than one central ray excision for the treatment of osteomyelitis with an
associated large soft tissue defect over the dorsum of the foot (Fig. 3).
Discussion
Diabetes mellitus has been estimated to affect 11 million Americans, and
of these, approximately 25% will develop foot problems. Furthermore, it
Fig. 3. Initial presentation of a severe midfoot abscess, ischemia, and central ray osteomyelitis
(A), followed by a resection of the central rays three and four and Ilizarov external fixation (B),
and final clinical and radiographic presentation after split-thickness skin grafting (C–E).
526 OZNUR & ZGONIS
has been shown that at least 15% of hospital admissions are directly related
to foot infections. Superficial and deep ulcers can be treated with nonoper-
ative techniques such as daily wound care, immobilization, and serial
debridements. Treatment of osteomyelitis in diabetic patients is time-
consuming because of vascular insufficiency, peripheral neuropathy, and
poor soft tissue coverage. If osteomyelitis or an abscess is present, an inci-
sion and drainage should be performed for treatment and obtaining
a deep tissue and bone culture [16–19].
A number of surgical techniques can maximize the success of wound heal-
ing. The most important is aggressive debridement of all infected tissue and
bone, while sparing the healthy tissue for closure. If the wound is grossly in-
fected at the initial debridement, serial surgical debridements is necessary
until the wound has responded and started to heal. Leaving large wounds
to heal by granulation and secondary intention may take several months
or years for a complete closure [20,21].
Antibiotic beads have primarily been used in the treatment of osteomye-
litis and compound fractures of the extremities. Antibiotic beads are fabri-
cated by mixing antibiotic powder into polymethylmethacrylate (PMMA)
cement pellets. While the PMMA mixture is still soft, small pellets are rolled
into shape and placed on a nonabsorbable suture. Too much antibiotic pre-
vents the beads from hardening, and too little antibiotic will limit the effec-
tiveness of the antibiotic beads. The chain of PMMA beads is loosely
packed into the wound or bone defect after radical surgical debridement
of all infected tissue and bone. A closed compartment is required to obtain
high local concentrations of antibiotic. The antibiotic is then released into
the wound by diffusion, with local antibiotic levels remaining very high
over 3 weeks. The exact diffusion rate of antibiotic varies by the brand of
PMMA cement, the concentration of antibiotic in the bead, the surface
area of the bead, and the type of antibiotics. High local concentrations of
antibiotic from antibiotic-impregnated PMMA beads have not caused tissue
toxicity or been shown to limit wound healing. The antibiotics added to
bone cement should be bactericidal, broad-spectrum antibiotics that are par-
ticularly effective against gram-positive cocci and gram-negative rods. In ad-
dition, the antibiotics should be thermo-stable (so as not to degrade during
exothermic polymerization reaction), and water-soluble. The antibiotics
should also have a low rate of developing resistant pathogens, and low al-
lergic potential. Antibiotics are generally used in a ratio of approximately
1 to 2 g of antibiotic to 40 g of bone cement. The aminoglycosides and van-
comycin are some of the better choices for antibiotic bead use, because of
their broad spectrum of activity, low incidence of reaction, and heat stabil-
ity. The antibiotic beads are usually removed within 2 to 4 weeks to prevent
overgrowth of granulation tissue.
Currently, there are limited reports describing the authors’ surgical ap-
proach for diabetic limb salvage, including the radical surgical debridement,
decreasing soft tissue and bone defect, and stabilization with an external
CLOSURE OF DIABETIC FOOT WOUNDS 527
References
[1] Hoar CS, Torres J. Evalution of of below-the-knee amputation in the treatment of diabetic
gangrene. N Engl J Med 1962;266:440–3.
[2] Aksoy DY, Gürlek A, Çetinkaya Y, et al. Change in the amputation profile in diabetic foot in
a tertiary reference center: efficacy of team working. Exp Clin Endocrinol Diabetes 2004;112:
526–30.
[3] Gibbons GW, Marccaccio EJ, Burgess ARN, et al. Improved quality of diabetic foot care,
1984 versus 1990. Reduced length of stay and costs, insufficient reimbursement. Arch Surg
1993;128:576–81.
[4] Zgonis T, Roukis TS. A systematic approach to diabetic foot infections. Adv Ther 2005;22:
244–62.
[5] Frykberg RG, Zgonis T, Armstrong DG, et al. Diabetic foot disorders: a clinical practice
quideline (2006 revision). J Foot Ankle Surg 2006;45(5 Suppl):S1–66.
[6] Cooper PS. Application of external fixators for management of Charcot deformities of the
foot and ankle. Semin Vasc Surg 2003;16:67–78.
[7] Cooper PS. Application of external fixators for management of Charcot deformities of the
foot and ankle. Foot Ankle Clin 2002;7:207–54.
[8] Jolly GP, Zgonis T, Polyzois V. External fixation in the management of Charcot neuroarthr-
opathy. Clin Podiatr Med Surg 2003;20:741–56.
[9] Baravarian B, Van Gils CC. Arthrodesis of the Charcot foot and ankle. Clin Podiatr Med
Surg 2004;21(2):271–89.
[10] Farber DC, Juliano PJ, Cavanagh PR, et al. Single stage correction with external fixation of
the ulcerated foot in individuals with Charcot neuroarthropathy. Foot Ankle Int 2002;23:
130–4.
[11] Roukis TS, Zgonis T. The management of acute Charcot fractureddislocation with the Tay-
lor’s spatial external fixation system. Clin Podiatr Med Surg 2006;23(2):467–83.
[12] Papa J, Myerson M, Girard P. Salvage with arthrodesis, in intractable diabetic neuropathic
arthropathy of the foot and ankle. J Bone Joint Surg Am 1993;75:1056–66.
[13] Oznur A. Management of large soft tissue defects in a diabetic patient. Foot Ankle Int 2003;
24(1):79–82.
[14] Oznur A, Tokgozoglu M. Closure of central defects of the forefoot with external fixation.
J Foot Ankle Surg 2004;43(1):56–9.
[15] Oznur A, Ozer H. Ray amputation with limited incision. Foot Ankle Int 2006;27(5):382.
[16] Roeder B, Van Gils CC, Maling S. Antibiotic beads in the treatment of diabetic pedal oste-
omyelitis. J Foot Ankle Surg 2000;39(2):124–30.
[17] Kumagai SG, Mahoney CR, Fitzgibbons TC, et al. Treatment of diabetic (neuropathic) foot
ulcers with two-stage debridement and closure. Foot Ankle Int 1998;19:160–5.
528 OZNUR & ZGONIS
[18] Pinzur MS, Sage R, Schaegler P. Ray resection in the dysvascular foot. Clin Orthop Relat
Res 1984;191:232–4.
[19] Smith DG, Stuck RM, Ketner L, et al. Partial calcanectomy for the treatment of large ulcer-
ations of the heel and calcaneal osteomyelitis. J Bone Joint Surg Am 1992;74:4571–6.
[20] Roukis TS, Zgonis T. Skin grafting techniques for soft-tissue coverage of diabetic foot and
ankle wounds. J Wound Care 2005;14:173–6.
[21] Pinzur MS, Sage R, Stuck R, et al. Amputations in the diabetic foot and ankle. Clin Orthop
Relat Res 1993;296:64–7.
[22] Strauss MB, Bryant BJ, Hart JD. Forefoot narrowing with external fixator for problem cleft
wounds. Foot Ankle Int 2002;23:433–9.
[23] Zgonis T, Oznur A, Roukis TS. A novel technique for closing difficult diabetic cleft foot
wounds with skin grafting and a ring-type external fixation system. Operative Techniques
Orthopaedics 2006;16:38–43.
[24] Zgonis T, Roukis TS, Frykberg RG, et al. Unstable acute and chronic Charcot’s deformity:
staged skeletal and soft tissue reconstruction. J Wound Care 2006;15:276–80.